Atipamezole HCl (CAS 104075-48-1): Veterinary Anesthesia Reversal API Guide

Atipamezole hydrochloride (Atipamezole HCl, CAS 104075-48-1) is a selective alpha-2 adrenergic receptor antagonist used in veterinary medicine to reverse sedative and analgesic effects of alpha-2 agonists such as medetomidine and dexmedetomidine. This guide is written for formulation scientists, buyers, and technical teams who need a deep, practical understanding of this API from both a pharmacological and manufacturing perspective.

What Is Atipamezole HCl?

Atipamezole HCl is a synthetic alpha-2 adrenergic receptor antagonist. In clinical practice it is primarily used as a reversal agent after alpha-2 agonist sedation in dogs, and in some regions also in cats and other small animals.

By competitively blocking alpha-2 receptors in the central nervous system, atipamezole displaces agents such as medetomidine and dexmedetomidine. This rapidly reduces alpha-2 mediated sedation, analgesia, and cardiovascular depression, helping animals wake up faster and recover physiological function.

From an API viewpoint, high purity Atipamezole HCl is used to manufacture:

• Veterinary injectable products for small animal anesthesia reversal
• Research formulations for pharmacology and anesthesia studies
• Comparative studies against other alpha-2 agonists and antagonists

Compared with older antagonists such as yohimbine, atipamezole offers higher alpha-2 selectivity and a more predictable recovery profile when dosed correctly.

What Are the Benefits of Atipamezole HCl?

Pharmacological and Clinical Advantages

• High alpha-2 selectivity
  Atipamezole shows strong selectivity for alpha-2 adrenergic receptors and minimal activity at alpha-1 receptors. This selectivity supports cardiovascular stability and reduces off target effects when reversing sedation.
• Fast and reliable reversal
  When given after medetomidine or dexmedetomidine, atipamezole typically produces rapid arousal. Dogs often regain posture, coordination, and normal reflexes within minutes, giving clinicians tight control over anesthesia duration.
• Better quality of recovery
  With appropriate dosing, animals experience smoother recoveries with less prolonged sedation, ataxia, or disorientation. This improves animal welfare and reduces handling risk for veterinary staff.
• Titratable effect
  The degree of reversal can be modulated by adjusting the atipamezole dose relative to the alpha-2 agonist dose. This allows full reversal when rapid recovery is needed or partial reversal when some residual sedation and analgesia are still desirable.

Operational Benefits in Veterinary Practice

• Shorter procedure and recovery time, allowing clinics to improve scheduling and throughput.
• Reduced post procedure monitoring burden because deep sedation and cardiovascular depression resolve more quickly.
• Additional safety margin in patients that show excessive sedation, bradycardia, hypotension, or delayed recovery after alpha-2 agonist use.

Manufacturing and Quality Advantages for Formulators

For manufacturers and formulation teams, a well controlled Atipamezole HCl API offers:

• High assay with tight impurity limits to support robust finished product specifications.
• Consistent solid state properties such as polymorphic form and particle size where controlled, improving dissolution and stability of injectable formulations.
• Reliable batch to batch consistency that reduces the risk of revalidation or bridging studies when scaling up or registering new markets.

What Are the Uses of Atipamezole HCl?

Core Therapeutic Uses

The main labeled indication for atipamezole in veterinary medicine is:

• Reversal of medetomidine or dexmedetomidine sedation in dogs after diagnostic or minor surgical procedures, dental work, or short therapeutic interventions.

In some regions and clinical protocols, atipamezole is also used in cats and other small animals to reverse alpha-2 agonist sedation, although exact indications and doses depend on local labeling and guidelines.

Extended and Off Label Uses

Under veterinary supervision and where regulations permit, atipamezole may also be used to:

• Reverse sedation produced by other alpha-2 agonists such as xylazine in selected species where evidence supports safety and efficacy.
• Support staged recoveries, where partial reversal is preferred so that some sedative and analgesic effect is maintained while the animal becomes more alert.

All extra label use should follow local regulations and evidence based veterinary practice.

Research and Experimental Uses

• Tool compound in pharmacology studies to dissect alpha-2 adrenergic pathways.
• Reversal agent in anesthesia experiments in laboratory animals.
• Reference antagonist in comparative efficacy and safety studies for new sedative and analgesic drugs.

Safety, Side Effects, and Regulatory Considerations

Common Side Effects

When used as directed, atipamezole is generally well tolerated, but the following effects have been reported:

• Transient excitement or hyperactivity as the animal transitions from sedation to wakefulness.
• Vocalization, muscle tremors, or ataxia during early recovery.
• Tachycardia and short term blood pressure changes related to alpha-2 reversal.
• Occasional gastrointestinal signs such as vomiting or diarrhea.

These effects are usually short lived. Animals should be monitored closely during and after recovery until they are stable and fully responsive.

Contraindications and Warnings

• Use with caution in animals with significant cardiovascular disease, where rapid shifts in autonomic tone may worsen underlying conditions or reveal arrhythmias.
• Avoid in patients with known hypersensitivity to atipamezole or formulation excipients.
• Full reversal may not be appropriate when continued sedation is needed for intensive care, wound protection, or observation.

Immediately after reversal, animals may be alert but not fully physiologically recovered. They should be kept in a controlled environment and not allowed unrestricted activity until the clinician is satisfied with their status.

Drug Interactions

• Atipamezole competitively antagonizes alpha-2 agonists including medetomidine, dexmedetomidine, and xylazine. Dose ratios should follow product labeling or validated protocols to avoid under reversal or over reversal.
• Interactions with cardiovascular drugs are possible due to changes in heart rate and blood pressure after reversal. Close monitoring is recommended in patients on cardioactive medication.
• Atipamezole does not reverse non alpha-2 components of anesthesia such as opioids or inhalant agents. Overall anesthetic depth and recovery still require comprehensive management.

Handling, Storage, and Occupational Safety

• Handle Atipamezole HCl API with appropriate personal protective equipment including gloves, eye protection, and a lab coat.
• Avoid inhalation of dust and work in a well ventilated area or controlled environment.
• Store in a cool, dry place protected from light in tightly closed original containers.
• In case of spills, absorb with inert material while wearing PPE and dispose of according to local regulations.

Chemical Specifications of Atipamezole HCl

The table below shows a typical specification profile for high quality Atipamezole HCl API. Individual projects can use customized limits based on regulatory and formulation needs.

Parameter	Typical specification	Примечания
Химическое название	Atipamezole hydrochloride	API grade
CAS number	104075-48-1	Reference identifier
Молекулярная формула	C14H15N2·HCl	Free base plus hydrochloride
Внешний вид	Белый или небелый кристаллический порошок	Visual inspection
Идентификация	Соответствует	By IR or HPLC against reference standard
Анализ (ВЭЖХ)	Not less than 99.0 percent (anhydrous basis)	Typical release limit
Сопутствующие вещества	Any single impurity not more than 0.15 percent; total impurities not more than 0.5 percent	Aligned with ICH impurity guidance
Остаточные растворители	Complies with ICH Q3C	By GC
Содержание воды	Not more than 1.0 percent	Karl Fischer titration
Elemental impurities	Complies with ICH Q3D	Measured by ICP based methods
pH (aqueous solution)	Typically 4.0 to 6.0	Defined concentration
Условия хранения	Store in a cool, dry place away from light	Keep in original container

Frequently Asked Questions About Atipamezole HCl

Is Atipamezole HCl suitable for finished veterinary injectable products?

Yes. Atipamezole HCl is widely used as an API in sterile injectable products that reverse alpha-2 agonist sedation in dogs and, in some regions, other small animals. The API grade and documentation package should match the intended regulatory pathway and target markets.

What documentation can be provided for Atipamezole HCl?

Depending on the project, typical support includes certificates of analysis, detailed specifications and analytical methods, stability data with recommended retest period, and regulatory documentation such as CTD sections or drug master files where available.

Can particle size or polymorph be customized?

For formulation sensitive projects, it is often possible to control particle size distribution and, where relevant, polymorphic form within agreed limits. This typically requires development work, validated analytical methods, and clear technical agreements.

Is Atipamezole HCl primarily for human or veterinary use?

Atipamezole is primarily a veterinary drug used for dogs and sometimes cats. Any use in humans would require separate dedicated development and regulatory approval and is not covered by typical veterinary registrations.

What are typical lead times and minimum order quantities?

Lead time and minimum order quantity depend on stock status, grade, and destination market. Many suppliers can provide small development samples first, followed by larger commercial batches once the formulation and registration strategy are defined.

Why Choose Our Atipamezole HCl?

Regulatory and Quality Support

• Production under quality systems aligned with good manufacturing practice for APIs.
• Technical and regulatory support for impurity profiles, stability, and method validation during registration.
• Specifications designed to be compatible with global expectations for API quality.

Consistent High Purity API

• Tight control of assay and impurities to support robust, reproducible formulations.
• Careful management of critical quality attributes such as residual solvents and elemental impurities.
• Stable supply with consistent quality across batches and production campaigns.

Technical Collaboration and Supply Reliability

• Technical teams familiar with veterinary anesthesia and reversal products.
• Support for method transfer, additional testing, or tailored specifications when projects require it.
• Flexible batch sizes for development, scale up, and commercial supply, with logistics adapted to destination market needs.

Related Veterinary and API Products

If you are working on veterinary anesthesia and perioperative care portfolios, you may also be interested in the following product categories on this site:

• Alpha-2 agonist veterinary APIs that are reversed by Atipamezole HCl.
• Other anesthesia and analgesia APIs for small animal and large animal practice.
• Supporting cardiovascular and critical care ingredients for perioperative use.

These related products can be linked internally from the Atipamezole HCl product page to strengthen topical authority and user navigation across the API and veterinary sections of the website.